http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012526792-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4458 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4458 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04 |
| filingDate | 2010-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012526792-A |
| titleOfInvention | Perhexiline for use in the treatment of hypertrophic cardiomyopathy (HCM) |
| abstract | The present invention requires an effective amount of perhexiline for use in the treatment of hypertrophic cardiomyopathy, or a pharmaceutically acceptable salt thereof, and perhexiline, or a pharmaceutically acceptable salt thereof, for treating said HCM The present invention relates to a method for treating HCM, comprising administering to an animal. The invention further relates to a therapeutic program for the treatment of HCM comprising the simultaneous use or administration of perhexiline together with HCM or one or more other compounds effective in the treatment of this indication. |
| priorityDate | 2009-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.